Works matching IS 08876924 AND DT 2015 AND VI 29 AND IP 8

Results: 24

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1702, doi. 10.1038/leu.2015.99

By:

Li, L;
Pongtornpipat, P;
Tiutan, T;
Kendrick, S L;
Park, S;
Persky, D O;
Rimsza, L M;
Puvvada, S D;
Schatz, J H

Publication type:

Article

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1713, doi. 10.1038/leu.2015.65

By:

Papanikolaou, X;
Alapat, D;
Rosenthal, A;
Stein, C;
Epstein, J;
Owens, R;
Yaccoby, S;
Johnson, S;
Bailey, C;
Heuck, C;
Tian, E;
Joiner, A;
van Rhee, F;
Khan, R;
Zangari, M;
Jethava, Y;
Waheed, S;
Davies, F;
Morgan, G;
Barlogie, B

Publication type:

Article

Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1779, doi. 10.1038/leu.2015.23

By:

Chen, X;
Newell, L F;
Xie, H;
Walter, R B;
Pagel, J M;
Sandhu, V K;
Becker, P S;
Hendrie, P C;
Abkowitz, J L;
Appelbaum, F R;
Estey, E H

Publication type:

Article

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1721, doi. 10.1038/leu.2015.80

By:

Mai, E K;
Bertsch, U;
Dürig, J;
Kunz, C;
Haenel, M;
Blau, I W;
Munder, M;
Jauch, A;
Schurich, B;
Hielscher, T;
Merz, M;
Huegle-Doerr, B;
Seckinger, A;
Hose, D;
Hillengass, J;
Raab, M S;
Neben, K;
Lindemann, H-W;
Zeis, M;
Gerecke, C

Publication type:

Article

Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1795, doi. 10.1038/leu.2015.40

By:

Hahn, C N;
Brautigan, P J;
Chong, C-E;
Janssan, A;
Venugopal, P;
Lee, Y;
Tims, A E;
Horwitz, M S;
Klingler-Hoffmann, M;
Scott, H S

Publication type:

Article

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1754, doi. 10.1038/leu.2015.75

By:

Olsson, R F;
Logan, B R;
Chaudhury, S;
Zhu, X;
Akpek, G;
Bolwell, B J;
Bredeson, C N;
Dvorak, C C;
Gupta, V;
Ho, V T;
Lazarus, H M;
Marks, D I;
Ringdén, O T H;
Pasquini, M C;
Schriber, J R;
Cooke, K R

Publication type:

Article

A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1668, doi. 10.1038/leu.2015.53

By:

Woessner, D W;
Eiring, A M;
Bruno, B J;
Zabriskie, M S;
Reynolds, K R;
Miller, G D;
O'Hare, T;
Deininger, M W;
Lim, C S

Publication type:

Article

The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1741, doi. 10.1038/leu.2015.74

By:

Ayllón, V;
Bueno, C;
Ramos-Mejía, V;
Navarro-Montero, O;
Prieto, C;
Real, P J;
Romero, T;
García-León, M J;
Toribio, M L;
Bigas, A;
Menendez, P

Publication type:

Article

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1798, doi. 10.1038/leu.2015.178

By:

Dolatshad, H;
Pellagatti, A;
Fernandez-Mercado, M;
Yip, B H;
Malcovati, L;
Attwood, M;
Przychodzen, B;
Sahgal, N;
Kanapin, A A;
Lockstone, H;
Scifo, L;
Vandenberghe, P;
Papaemmanuil, E;
Smith, C W J;
Campbell, P J;
Ogawa, S;
Maciejewski, J P;
Cazzola, M;
Savage, K I;
Boultwood, J

Publication type:

Article

The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1789, doi. 10.1038/leu.2015.34

By:

Momose, S;
Weißbach, S;
Pischimarov, J;
Nedeva, T;
Bach, E;
Rudelius, M;
Geissinger, E;
Staiger, A M;
Ott, G;
Rosenwald, A

Publication type:

Article

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1656, doi. 10.1038/leu.2015.107

By:

Malinowska-Ozdowy, K;
Frech, C;
Schönegger, A;
Eckert, C;
Cazzaniga, G;
Stanulla, M;
zur Stadt, U;
Mecklenbräuker, A;
Schuster, M;
Kneidinger, D;
von Stackelberg, A;
Locatelli, F;
Schrappe, M;
Horstmann, M A;
Attarbaschi, A;
Bock, C;
Mann, G;
Haas, O A;
Panzer-Grümayer, R

Publication type:

Article

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1695, doi. 10.1038/leu.2015.60

By:

Hess, G;
Keller, U;
Scholz, C W;
Witzens-Harig, M;
Atta, J;
Buske, C;
Kirschey, S;
Ruckes, C;
Medler, C;
van Oordt, C;
Klapper, W;
Theobald, M;
Dreyling, M

Publication type:

Article

Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1771, doi. 10.1038/leu.2015.58

By:

Hyde, R K;
Zhao, L;
Alemu, L;
Liu, P P

Publication type:

Article

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1637, doi. 10.1038/leu.2015.52

By:

Kenderian, S S;
Ruella, M;
Shestova, O;
Klichinsky, M;
Aikawa, V;
Morrissette, J J D;
Scholler, J;
Song, D;
Porter, D L;
Carroll, M;
June, C H;
Gill, S

Publication type:

Article

The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1623, doi. 10.1038/leu.2015.113

By:

Eswaran, J;
Sinclair, P;
Heidenreich, O;
Irving, J;
Russell, L J;
Hall, A;
Calado, D P;
Harrison, C J;
Vormoor, J

Publication type:

Article

The DEK oncoprotein and its emerging roles in gene regulation.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1632, doi. 10.1038/leu.2015.72

By:

Sandén, C;
Gullberg, U

Publication type:

Article

Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1781, doi. 10.1038/leu.2015.26

By:

Riether, C;
Gschwend, T;
Huguenin, A-L;
Schürch, C M;
Ochsenbein, A F

Publication type:

Article

Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1676, doi. 10.1038/leu.2015.50

By:

Wild, J;
Schmiedel, B J;
Maurer, A;
Raab, S;
Prokop, L;
Stevanović, S;
Dörfel, D;
Schneider, P;
Salih, H R

Publication type:

Article

Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1792, doi. 10.1038/leu.2015.35

By:

Lu, L;
Saunders, V A;
Leclercq, T M;
Hughes, T P;
White, D L

Publication type:

Article

Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1648, doi. 10.1038/leu.2015.59

By:

Eckert, C;
Hagedorn, N;
Sramkova, L;
Mann, G;
Panzer-Grümayer, R;
Peters, C;
Bourquin, J-P;
Klingebiel, T;
Borkhardt, A;
Cario, G;
Alten, J;
Escherich, G;
Astrahantseff, K;
Seeger, K;
Henze, G;
von Stackelberg, A

Publication type:

Article

AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1730, doi. 10.1038/leu.2015.56

By:

Gao, X N;
Yan, F;
Lin, J;
Gao, L;
Lu, X L;
Wei, S C;
Shen, N;
Pang, J X;
Ning, Q Y;
Komeno, Y;
Deng, A L;
Xu, Y H;
Shi, J L;
Li, Y H;
Zhang, D E;
Nervi, C;
Liu, S J;
Yu, L

Publication type:

Article

F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1763, doi. 10.1038/leu.2015.70

By:

Gorantla, S P;
Zirlik, K;
Reiter, A;
Yu, C;
Illert, A L;
Von Bubnoff, N;
Duyster, J

Publication type:

Article

IL10 receptor is a novel therapeutic target in DLBCLs.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1684, doi. 10.1038/leu.2015.57

By:

Béguelin, W;
Sawh, S;
Chambwe, N;
Chan, F C;
Jiang, Y;
Choo, J-W;
Scott, D W;
Chalmers, A;
Geng, H;
Tsikitas, L;
Tam, W;
Bhagat, G;
Gascoyne, R D;
Shaknovich, R

Publication type:

Article

Cellular origin of prognostic chromosomal aberrations in AML patients.

Published in:

Leukemia (08876924), 2015, v. 29, n. 8, p. 1785, doi. 10.1038/leu.2015.30

By:

Mora-Jensen, H;
Jendholm, J;
Rapin, N;
Andersen, M K;
Roug, A S;
Bagger, F O;
Bullinger, L;
Winther, O;
Borregaard, N;
Porse, B T;
Theilgaard-Mönch, K

Publication type:

Article